ArticleClinical oral investigations2026
Stratified discharge timing within mucositis cases and its association with systemic complications in hematopoietic stem cell transplant recipients: insights from a national inpatient study.
Article in Clinical oral investigations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundOral ulcerative mucositis (OUM) is a frequent and severe complication of hematopoietic cell transplantation (HCT). Whether prolonged hospital discharge timing, used as a proxy for extended length of stay (LOS), identifies greater systemic morbidity among patients who develop OUM remains unclear. This retrospective cohort study aimed to evaluate, among HCT recipients with documented OUM, whether prolonged discharge timing is independently associated with increased systemic complications.
methodsThis retrospective cohort study utilized the National Inpatient Sample to identify adult patients with leukemia or multiple myeloma undergoing autologous or allogeneic HCT complicated by OUM. Patients were stratified by discharge timing: autologous HCT, 10-19 (control) vs. 20-29 days; allogeneic HCT, 15-24 (control) vs. 25-34 days. Further, no control group of patients undergoing HCT without OUM was examined. Baseline characteristics and systemic outcomes-including healthcare-associated complications incorporating septicemias, isolated septicemia, coagulopathies, hypertension, and congestive heart failure-were compared. Survey-weighted multivariable logistic regression estimated adjusted odds ratios (aOR) for outcomes in prolonged versus shorter discharge strata, adjusting for demographics and comorbidity burden.
resultsAmong autologous HCT recipients with OUM (weighted n = 1290), 21.7% experienced prolonged discharge. This stratum had significantly higher adjusted rates of healthcare-associated complications, including septicemias (aOR 3.09, 95% CI: 1.45-6.59), isolated septicemia (aOR 4.68, 95% CI: 1.83-11.96), and congestive heart failure (aOR 1.68, 95% CI: 2.44-11.58). Among allogeneic HCT recipients (weighted n = 885), 54.2% had prolonged discharge, associated with increased healthcare-associated complications including septicemias (aOR 3.3, 95% CI: 1.19-9.12), coagulopathies (aOR 3.47 with 95% CI: 1.33-9.03), and hypertension (aOR 2.00 with 95%CI: 1.05-3.82). No adverse outcomes occurred in discharges within 0-10 days.
conclusionsProlonged discharge timing in HCT patients with OUM is independently associated with substantial systemic morbidity, including septicemia-related complications. Discharge-based stratification highlights high-risk periods amenable to targeted supportive interventions to mitigate complications and facilitate earlier safe discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.